David E Scheim

6PUBLICATIONS
10CO-AUTHORS
GlycoconjugatesInfectious diseasesHaematological tumoursPredictive and prognostic markersVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2024
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.

David E Scheim, Peter I Parry, David J Rabbolini

|Dec 09, 2023
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19.

David E Scheim, Paola Vottero, Alessandro D Santin

|Jul 29, 2023
Computational Prediction of the Interaction of Ivermectin with Fibrinogen.

Paola Vottero, Scott Tavernini, Alessandro D Santin

|Jun 10, 2023
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples.

David E Scheim, Colleen Aldous, Barbara Osimani

|Dec 23, 2022
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects.

Celine Boschi, David E Scheim, Audrey Bancod

|Mar 10, 2022
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody.

David E Scheim

Pageof 1

Frequent Collaborators

2 joint publications

Alessandro D Santin

1 joint publications

Philippe Colson

1 joint publications

Jacques Fantini

1 joint publications

Bernard La Scola